Puerarin Protects against Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis
Authors:
Open Access
- 1 April 2023
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 46 (4) , 524-532
Abstract
This study investigated whether pretreatment with puerarin could alleviate myocardial ischemia/reperfusion (I/R) injury in a cardiomyocyte oxygen–glucose deprivation and reoxygenation (OGD/R) model and in a mouse I/R injury model. For in vitro experiments, H9C2 cells were divided into control, erastin, OGD/R, OGD/R + puerarin, and OGD/R + ferrostatin (Fer)-1 groups. Parameters related to ferroptosis included levels of malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), ATP, reactive oxygen species (ROS), glutathione (GSH), prostaglandin endoperoxide synthase (Ptgs) 2 mRNA, glutathione peroxidase (GPX) 4 protein and iron. In H9C2 cells, puerarin or Fer-1 pretreatment reduced ferroptosis, as indicated by decreased ROS and increased GSH, ATP levels. In vivo, wild-type mice were randomly divided into sham, I/R + vehicle, I/R + puerarin, and IR + Fer-1 groups. The I/R model was established by 30 min of left anterior descending artery occlusion followed by 24 h of reperfusion. Pretreatment with puerarin or Fer-1 significantly reduced infarct size in I/R mice, and decreased the activities of Myeloperoxidase (MPO) and cardiac enzymes such as creatine kinase MB isoenzyme (CK-MB), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) compared to those in the vehicle-treated group. Puerarin also reduced the production of MDA and 4-HNE, reduced the mRNA expression of Ptgs2 mRNA, and increased GPX4 protein expression. These results showed that puerarin exerted protective effects against myocardial I/R injury by inhibiting ferroptosis and inflammation, and therefore may have therapeutic potential for treatment of acute myocardial infarction.Keywords
This publication has 44 references indexed in Scilit:
- Synchronized renal tubular cell death involves ferroptosisProceedings of the National Academy of Sciences of the United States of America, 2014
- Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathwaysActa Pharmacologica Sinica, 2014
- The protective effects of puerarin in cardiomyocytes from anoxia/reoxygenation injury are mediated by PKCεCell Biochemistry and Function, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Puerarin: A Review of Pharmacological EffectsPhytotherapy Research, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunctionFree Radical Biology and Medicine, 2008
- Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarinEuropean Journal of Pharmacology, 2007
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Decrease in Mitochondrial Complex I Activity in Ischemic/Reperfused Rat HeartCirculation Research, 2004